Search

Your search keyword '"Callery, James J."' showing total 157 results

Search Constraints

Start Over You searched for: Author "Callery, James J." Remove constraint Author: "Callery, James J."
157 results on '"Callery, James J."'

Search Results

1. Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial

2. Expanding the roles of community health workers to sustain programmes during malaria elimination: a meeting report on operational research in Southeast Asia

3. Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial

4. Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial

6. Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial

7. Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial

8. Field evaluation of the diagnostic performance of EasyScan GO: a digital malaria microscopy device based on machine-learning

10. Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)

13. Expanding the role of village malaria workers in Cambodia: Implementation and evaluation of four health education packages

14. Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial

15. Artemisinin-resistant malaria in Africa demands urgent action.

16. Clinical antiviral efficacy of remdesivir in COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV)

17. The feasibility of novel point-of-care diagnostics for febrile illnesses at health centres in Southeast Asia: a mixed-methods study

18. Community engagement among forest goers in a malaria prophylaxis trial: implementation challenges and implications

19. Tools to accelerate falciparum malaria elimination in Cambodia: a meeting report

20. Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open- label, randomised, controlled adaptive platform trial

21. Glucose-6-Phosphate Dehydrogenase (G6PD) Measurement Using Biosensors by Community-Based Village Malaria Workers and Hospital Laboratory Staff in Cambodia: A Quantitative Study

23. Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV).

24. Author response: Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)

25. Effectiveness of community engagement among forest goers in a malaria prophylaxis trial: Implementation challenges and implications

26. Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries

27. Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study

28. Clinical antiviral efficacy of remdesivir and casirivimab/imdevimab against the SARS-CoV-2 Delta and Omicron variants

29. Pharmacometric assessment of the in vivo antiviral activity of ivermectin in early symptomatic COVID-19

31. Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV).

32. Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project

33. Additional file 2 of Glucose 6 Phosphate Dehydrogenase (G6PD) quantitation using biosensors at the point of first contact: a mixed method study in Cambodia

34. Additional file 2 of Field evaluation of the diagnostic performance of EasyScan GO: a digital malaria microscopy device based on machine-learning

35. Additional file 3 of Field evaluation of the diagnostic performance of EasyScan GO: a digital malaria microscopy device based on machine-learning

36. Additional file 1 of Field evaluation of the diagnostic performance of EasyScan GO: a digital malaria microscopy device based on machine-learning

38. Additional file 3 of Glucose 6 Phosphate Dehydrogenase (G6PD) quantitation using biosensors at the point of first contact: a mixed method study in Cambodia

39. Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study

40. Evolution of Multidrug Resistance in Plasmodium falciparum: a Longitudinal Study of Genetic Resistance Markers in the Greater Mekong Subregion

43. Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project

44. Additional file 1 of Tools to accelerate falciparum malaria elimination in Cambodia: a meeting report

45. Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; protocol for a randomised, placebo-controlled prophylaxis study (COPCOV)

47. Genetic surveillance in the Greater Mekong Subregion and South Asia to support malaria control and elimination

48. Initiating a network to support engagement between health researchers and schools: recommendations from an international meeting of schools engagement practitioners held in Kilifi, Kenya

49. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial

50. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparummalaria: a multicentre, open-label, randomised clinical trial

Catalog

Books, media, physical & digital resources